Summary of all studies containing PUBCHEM ID 10267
Project | Study | Study_title | Subject_type | Subject_species | Metabolite_name |
---|---|---|---|---|---|
PR000232 | ST000564 | 2014 Biotron Experiment Metabolites (part II) | Plant | Zea mays | Fructose 1,6-bisphosphate [Data] |
PR000269 | ST000424 | Metabolomics Approach to Allograft Assessment in Liver Transplantation (part II) | Human | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR000362 | ST000475 | Metabolomic testing of a putative MDH inhibitor (global) | Human leukemia cells | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR000626 | ST000900 | Evidence that the metabolite repair enzyme NAD(P)HX epimerase has a moonlighting function | Cells | Escherichia coli | fructose-1,6-bisphosphate [Data] |
PR000758 | ST001133 | Downregulation of CENPF epigenetically remodels prostate cancer cells and alters cellular metabolism | Cultured cells | Homo sapiens | fructose-1,6-bisphosphate [Data] |
PR001047 | ST001637 | A Metabolome Atlas of the Aging Mouse Brain | Mammal | Mus musculus | Fructose-1,6-bisphosphate [Data] |
PR001047 | ST001888 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Mammal | Mus musculus | Fructose-1,6-bisphosphate [Data] |
PR001072 | ST001669 | Serum metabolome of Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | fructose-1;6-bisphosphate M0 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | fructose-1;6-bisphosphate M1 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | fructose-1;6-bisphosphate M2 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | fructose-1;6-bisphosphate M3 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | fructose-1;6-bisphosphate M4 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | fructose-1;6-bisphosphate M5 [Data] |
PR001094 | ST001709 | SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition | Cultured cells | Homo sapiens | fructose-1;6-bisphosphate M6 [Data] |
PR001132 | ST001779 | Untargeted Metabolomics analysis of A549 treated with 0.5 mM extracellular ATP and 10 ng/ml TGF-beta | Cultured cells | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001213 | ST001922 | Sublytic membrane attack complex drives glycolysis and mitochondrial dysfunction with inflammatory consequences in human monocyte-derived macrophages | Human | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001241 | ST001954 | A pathogenic role for histone H3 copper reductase activity in a yeast model of Friedreich’s Ataxia | Yeast | Saccharomyces cerevisiae | fructose-1;6-bisphosphate [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | F16P-m0 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | F16P-m1 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | F16P-m2 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | F16P-m3 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | F16P-m4 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | F16P-m5 [Data] |
PR001305 | ST002061 | Glutamine flux in macrophages treated with stable-isotope labeled analog 4 mM (U-13C5) glutamine | Cultured cells | Mus musculus | F16P-m6 [Data] |
PR001340 | ST002115 | LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells | Cultured cells | Homo sapiens | fructose-1-6-bisphosphate [Data] |
PR001418 | ST002220 | Catabolism of branched-chain amino acids (BCAAs) in renal cells HK2 and 786-O | Cultured cells | Homo sapiens | fructose bisphosphate [Data] |
PR001418 | ST002221 | Glutaminolysis contribution to the carbon backbone of aspartate through ATP Citrate Lyase (ACLY) in ccRCC | Cultured cells | Homo sapiens | fructose bisphosphate [Data] |
PR001418 | ST002222 | Glutaminolysis contribution to the carbon backbone of aspartate and glutamate in ccRCC | Cultured cells | Homo sapiens | fructose bisphosphate [Data] |
PR001418 | ST002224 | Intracellular metabolic profile of renal cells cultured in Plasmax | Cultured cells | Homo sapiens | fructose bisphosphate [Data] |
PR001500 | ST002337 | Guangzhou Nutrition and Health Study (GNHS) | Human | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001524 | ST002371 | High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages | Cultured cells | Mus musculus | beta-D-Fructose 1,6-bisphosphate [Data] |
PR001678 | ST002708 | Levels of central carbon metabolites in choroid plexus as part of natural diurnal variation | Mammal | Mus musculus | Fructose 1,6-bisphosphate [Data] |
PR001679 | ST002709 | FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer | Cultured cells | NCCFH1; UOK262; UTFHC1 | fructose-1;6-bisphosphate [Data] |
PR001686 | ST002719 | Comparison of metabolic of A549 cells before and after Gossypol acetate (GAA) treatment | Cultured cells | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001761 | ST002814 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy | Mammal | Mus musculus | fructose-1;6-bisphosphate [Data] |
PR001761 | ST002878 | Atlas of fetal metabolism during mid-to-late gestation and diabetic pregnancy. Dynamic Labelling experiment. | Mammal | Mus musculus | fructose-1;6-bisphosphate [Data] |
PR001786 | ST002852 | MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer | Mammal | Mus musculus | fructose-1;6-bisphosphate [Data] |
PR001814 | ST002919 | Short-term metabolic insulin response of DINCH- and MINCH-treated cells | Cultured cells | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001814 | ST002920 | Possible PPARG-independent effects of DINCH and MINCH on central carbon metabolism | Cultured cells | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001814 | ST002922 | Effects of DINCH and MINCH on adipocyte metabolism of human SGBS cells. | Cultured cells | Homo sapiens | Fructose 1,6-bisphosphate [Data] |
PR001819 | ST003174 | O-GlcNAcase activity maintains stress granules for proximity-enhanced ATP production to ensure recovery from stress (Part 3) | Cultured cells | Homo sapiens | fructose-1,6-bisphosphate [Data] |
PR001941 | ST003431 | Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. | Cultured cells | Homo sapiens | Fructose-1,6-bisphosphate 177 [Data] |
PR001941 | ST003431 | Metabolomics analysis of breast cancer cell lines treated with dimethylmalonate (DMM), GSK2194069, and their combination. | Cultured cells | Homo sapiens | Fructose-1,6-bisphosphate 97 [Data] |
PR001941 | ST003432 | Intracellular and medium metabolomics of BT-474 cells treated with LW6 | Cultured cells | Homo sapiens | Fructose-1,6-bisphosphate 177 [Data] |
PR001941 | ST003432 | Intracellular and medium metabolomics of BT-474 cells treated with LW6 | Cultured cells | Homo sapiens | Fructose-1,6-bisphosphate 97 [Data] |
PR001941 | ST003433 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Homo sapiens | Fructose-1,6-bisphosphate 177 [Data] |
PR001941 | ST003433 | Intracellular and medium metabolomics of BT-474 cells treated with dimethylmalonate, Fasnall, and GSK2194069 | Cultured cells | Homo sapiens | Fructose-1,6-bisphosphate 97 [Data] |
PR001941 | ST003434 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Mammal | Mus musculus | Fructose-1,6-bisphosphate 177 [Data] |
PR001941 | ST003434 | Plasma concentrations of Fasnall in mice after a bolus of 10 mg/kg administered intraperitoneally. | Mammal | Mus musculus | Fructose-1,6-bisphosphate 97 [Data] |
PR001941 | ST003435 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Fish | Danio rerio | Fructose-1,6-bisphosphate 177 [Data] |
PR001941 | ST003435 | Metabolomics analysis of zebrafish embryos treated with rotenone, Fasnall, TVB-2640, and GSK2194069 | Fish | Danio rerio | Fructose-1,6-bisphosphate 97 [Data] |
PR001941 | ST003436 | Pharmacokinetics of Fasnall in NSG mice | Mammal | Mus musculus | Fructose-1,6-bisphosphate 177 [Data] |
PR001941 | ST003436 | Pharmacokinetics of Fasnall in NSG mice | Mammal | Mus musculus | Fructose-1,6-bisphosphate 97 [Data] |
PR002082 | ST003499 | Metabolic analysis of ADSL deficiency patients' EBV-LCLs. | Cultured cells | Homo sapiens | fructose 1,6-bisphosphate [Data] |